(2) Adjusted
The term "adjusted" refers to the proportional consolidation of Litha's results. Given that Litha is being accounted for on a consolidated basis, the consolidated results include amounts attributable to minority shareholders. Consequently, adjusted results have been provided to highlight Paladin's 44.54% economic interest in Litha's results.
Conference Call Notice
Paladin will host a conference call to discuss its fourth quarter results today at 10:00 a.m. EST. The dial-in number for the conference call is 1-800-736-4594 or 416-981-9000. The call will be audio-cast live and archived for 30 days at www.paladinlabs.com.
About Paladin Labs Inc.
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information, please visit the Company's web site at www.paladinlabs.com.
This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2011. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly filings, annual report and Annual Information Form and other fillings found on SEDAR at www.sedar.com.
CONSOLIDATED BALANCE SHEETS(In thousands of Canadian dollars)As at December 31, 2012 December 31, 2011 $ $----------------------------------------------------------------------------ASSETS (unaudited) (audited(3))CurrentCash and cash equivalents 118,744 72,115Marketable securities 146,258 166,894Trade and other receivables 38,587 20,208Inventories 37,441 13,327Income tax receivable 5,479 718Other current assets 1,661 1,476----------------------------------------------------------------------------Total current assets 348,170 274,738Investment in associates 626 20,850Interest in a joint venture 30,476 -Loans receivable from a joint venture 11,661 -Financial assets 4,561 9,311Investment tax credits recoverable 24,840 24,674Deferred income tax assets 25,402 40,613Property, plant and equipment 9,754 162Intangible assets 112,851 27,565Goodwill 36,176 -----------------------------------------------------------------------------Total assets 604,517 397,913--------------------------------------------------------------------------------------------------------------------------------------------------------LIABILITIES AND EQUITYCurrentBank overdraft 7,044 -Payables, accruals and provisions 50,165 38,849Finance lease liability 796 984Deferred revenue 2,734 2,999Income tax payable 24,140 22,205Other balances payable 2,000 2,306Long-term liabilities 5,804 -----------------------------------------------------------------------------Total current liabilities 92,683 67,343Finance lease liability 6,843 5,745Deferred revenue 1,734 2,099Deferred tax liability 24,415 -Long-term liabilities 28,327 -----------------------------------------------------------------------------Total liabilities 154,002 75,187--------------------------------------------------------------------------------------------------------------------------------------------------------EquityShare capital 172,282 166,681Other paid-in capital 7,039 5,144Other capital reserves (4,076) 553Retained earnings 208,461 150,348----------------------------------------------------------------------------Attributable to shareholders of the Company 383,706 322,726Non-controlling interests 66,809 -----------------------------------------------------------------------------Total equity 450,515 322,726----------------------------------------------------------------------------Total liabilities and equity 604,517 397,913--------------------------------------------------------------------------------------------------------------------------------------------------------CONSOLIDATED INCOME STATEMENTS(In thousands of Canadian dollars except for share and per share amounts) Three months ended Twelve months ended December 31 December 31 2012 2011 2012 2011 $ $ $ $---------------------------------------------------------------------------- (unaudited) (unaudited) (unaudited) (audited(3)) Revenues 67,608 37,083 210,200 141,466 Cost of sales 28,388 11,543 76,810 39,294---------------------------------------------------------------------------- Gross income 39,220 25,540 133,390 102,172---------------------------------------------------------------------------- Expenses (income) Selling, general and administrative 15,508 9,049 49,013 31,983 Research and development 1,813 3,628 7,794 9,773 Interest income (2,123) (1,089) (5,460) (7,296)---------------------------------------------------------------------------- Earnings before under- noted items 24,022 13,952 82,043 67,712---------------------------------------------------------------------------- Amortization of intangible assets 5,565 6,168 16,132 22,028 Depreciation of property, plant and equipment 445 19 703 136 Other finance expense (income) 314 (70) 1,164 (8,687) Other income 71 - (3,035) (97) Foreign exchange loss 1,089 284 1,211 80 Interest expense 1,225 18 2,181 18 Share of net loss from a joint venture (46) - 725 - Share of net income from associates (19) (660) (999) (1,756)---------------------------------------------------------------------------- Income before income tax and under-noted items 15,378 8,193 63,961 55,990---------------------------------------------------------------------------- Purchase gain on business combination - (17,070) - (17,070) Gain on revaluation of equity investment - - (12,294) - Restructuring, shutdown and other costs - 8,795 - 8,795---------------------------------------------------------------------------- Income before income tax 15,378 16,468 76,255 64,265 Provision for income taxes 3,958 696 17,900 14,114---------------------------------------------------------------------------- Net income for the year 11,420 15,772 58,355 50,151---------------------------------------------------------------------------- Attributable to: Shareholders of the Company 12,834 15,772 59,906 50,151 Non-controlling interests (1,414) - (1,551) -----------------------------------------------------------------------------Attributable to shareholdersBasic earnings per share 0.63 0.78 2.94 2.51Diluted earnings per share 0.61 0.76 2.86 2.43Weighted average number of shares outstandingBasic 20,402,565 20,232,947 20,347,805 19,970,658Diluted 20,963,327 20,849,408 20,946,178 20,659,276----------------------------------------------------------------------------CONSOLIDATED STATEMENTS OF CASH FLOWSPeriods ended December Three months ended Twelve months ended 31 December 31, 2012 December 31, 2012(In thousands of Canadian dollars) 2012 2011 2012 2011 $ $ $ $---------------------------------------------------------------------------- (unaudited) (unaudited) (unaudited) (audited(3))Operating activitiesNet income for the year 11,420 15,772 58,355 50,151Adjustments reconciling net income to operating cash flows Amortization of intangible assets 5,565 6,168 16,132 22,028 Deferred tax 4,276 (1,144) 15,845 2,577 Share-based compensation expense 966 438 3,216 1,946 Other finance expense (income) 318 (69) 1,164 (8,687) Unrealized foreign exchange loss (gain) 1,467 825 1,143 (7) Gain on revaluation of equity investment - - (12,294) - Other income (3) - (2,838) - Depreciation of property, plant and equipment 460 22 726 187 Share of net income from associates (19) (660) (999) (1,756) Share of net loss from a joint venture (46) - 725 - Purchase gain on business combination - (17,070) - (17,070) Restructuring, shutdown and other costs - 3,946 - 3,946---------------------------------------------------------------------------- 24,404 8,228 81,175 53,315----------------------------------------------------------------------------Net change in non-cash balances relating to operations (1,407) 3,913 (11,572) 14,798----------------------------------------------------------------------------Cash inflow from operating activities 22,997 12,141 69,603 68,113----------------------------------------------------------------------------Investing activitiesDisposals and maturities of marketable securities 47,474 27,020 187,575 78,373Dividends from an associate - 1,980 3,319 2,871Proceeds from disposal of financial assets 5,785 13,109 6,620 102,119Proceeds from disposal of intangible assets 749 - 1,466 -Proceeds from disposal of property, plant and equipment 180 - 220 -Acquisition of subsidiaries, net of cash acquired (2) (1,109) (42,358) (1,109)Purchases of marketable securities (46,636) (50,561) (167,615) (201,618)Purchases of financial assets - (1,000) (4,000) (89,873)Payment of other balances payable - - (995) (250)Purchases of property, plant and equipment (926) (9) (1,453) (78)Additions to intangible assets (1,004) - (1,111) (7,617)Investment in an associate - - - (2,936)----------------------------------------------------------------------------Net cash inflow (outflow) from investing activities 5,620 (10,570) (18,332) (120,118)----------------------------------------------------------------------------Financing activitiesCommon shares issued for cash, net of issue costs of $nil (2011: $1,643) 127 880 1,478 41,918Increase in bank overdraft 634 - 1,353 -Repurchase of shares - (259) (2,278) (580)Settlement of finance lease liability - - (3,366) -Repayment of long-term liabilities (1,230) (13,241) (1,766) (13,241)Payment of obligation under finance lease - (167) (500) (167)----------------------------------------------------------------------------Net cash (outflow) inflow from financing activities (469) (12,787) (5,079) 27,930----------------------------------------------------------------------------Foreign exchange gain (loss) on cash and cash equivalents 12 - 437 (105)Increase (decrease) in cash and cash equivalents during the period 28,160 (11,216) 46,629 (24,180)Cash and cash equivalents, beginning of period 90,584 83,331 72,115 96,295----------------------------------------------------------------------------Cash, cash equivalents, end of period 118,744 72,115 118,744 72,115--------------------------------------------------------------------------------------------------------------------------------------------------------Paladin cash and cash equivalents 113,229 72,115Paladin marketable securities 146,258 166,894----------------------------------------------------------------------------Paladin cash, cash equivalents and marketable securities 259,487 239,009----------------------------------------------------------------------------Litha cash and cash equivalents 5,515 -Litha bank overdraft (7,044) -----------------------------------------------------------------------------Litha cash and cash equivalents and bank overdraft (1,529) -----------------------------------------------------------------------------Cash, cash equivalents and marketable securities net of bank overdraft 257,958 239,009---------------------------------------------------------------------------- Reconciliation of the adjusted(2) consolidated results from operations Adjusted(2) Consolidated consolidatedThree months ended results from Litha results from December 31, 2012 Paladin Litha 100% operations 44.54% operations $ $ $ $ $----------------------------------------------------------------------------Revenues 40,509 27,099 67,608 12,070 52,579Cost of sales 12,023 16,365 28,388 7,289 19,312----------------------------------------------------------------------------Gross Income 28,486 10,734 39,220 4,781 33,267EBITDA(1) 21,833 2,189 24,022 975 22,808Net income (loss) before income taxes 18,742 (3,364) 15,378 (1,498) 17,244Net Income (loss) 13,973 (2,553) 11,420 (1,137) 12,836Net Income (loss) attributable to shareholders 13,973 (1,139) 12,834 (1,139) 12,834----------------------------------------------------------------------------Twelve months ended Adjusted(2) December 31, 2012 Consolidated consolidated results from Litha results from Paladin Litha 100% operations 44.54% operations $ $ $ $ $----------------------------------------------------------------------------Revenues 153,873 56,327 210,200 25,088 178,961Cost of sales 44,112 32,698 76,810 14,564 58,676----------------------------------------------------------------------------Gross Income 109,761 23,629 133,390 10,524 120,285EBITDA(1) 76,521 5,522 82,043 2,459 78,980Net income (loss) before income taxes 79,479 (3,224) 76,255 (1,436) 78,043Net Income (loss) 61,065 (2,710) 58,355 (1,207) 59,858Net Income (loss) attributable to shareholders 61,065 (1,159) 59,906 (1,159) 59,906----------------------------------------------------------------------------
(3) Derived from the audited annual financial statements filed on SEDAR at http://www.sedar.com/
Contacts:
Samira Sakhia
Chief Financial Officer
Paladin Labs Inc.
Tel: 514-669-5367
514-344-4675 (FAX)
Email: info@paladinlabs.com
Website: www.paladinlabs.com



